A Single-center Experience on the Value of Pancreas Graft Biopsies and HLA Antibody Monitoring After Simultaneous Pancreas-Kidney Transplantation
- 27 October 2015
- journal article
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 47 (8), 2504-2512
- https://doi.org/10.1016/j.transproceed.2015.09.013
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Efficacy and Safety of Alemtuzumab and Daclizumab Versus Antithymocyte Globulin During Organ Transplantation: A Meta-AnalysisTransplantation Proceedings, 2012
- Posttransplant Donor-Specific Anti-HLA Antibodies Negatively Impact Pancreas Transplantation OutcomeAmerican Journal of Transplantation, 2011
- Guidelines for the Diagnosis of Antibody-Mediated Rejection in Pancreas Allografts—Updated Banff Grading SchemaAmerican Journal of Transplantation, 2011
- Pancreas Transplantation: Lessons Learned From a Decade of Experience at Wake Forest Baptist Medical CenterThe Review of Diabetic Studies, 2011
- Pancreas Allograft Rejection: Analysis of Concurrent Renal Allograft Biopsies and Posttherapy Follow-Up BiopsiesTransplantation, 2010
- Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantationTransplant International, 2009
- Tools for Human Leukocyte Antigen Antibody Detection and Their Application to Transplanting Sensitized PatientsTransplantation, 2008
- Banff Schema for Grading Pancreas Allograft Rejection: Working Proposal by a Multi-Disciplinary International Consensus PanelAmerican Journal of Transplantation, 2008
- Correlation of genetic markers of rejection with biopsy findings following human pancreas transplantClinical Transplantation, 2005
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999